IP Library Granted Patent US 7,758,555
Granted Patent B2
US 7,758,555 · App. 11/903,165 · Granted Jul 20, 2010

Reduced pressure treatment system having blockage clearing and dual-zone pressure protection capabilities

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,758,555
App. No.
11/903,165
Granted
Jul 20, 2010
Kind
B2
Abstract

A method of treating a tissue site is provided. The method includes applying a reduced pressure to a tissue site with a reduced pressure source. A source pressure is monitored at the reduced pressure source, and a differential pressure is determined between the source pressure and the desired tissue site pressure. If a blockage is present between the reduced pressure source and the tissue site, the differential pressure is limited to a first maximum differential pressure. If no blockage is present between the reduced pressure source and the tissue site, the differential pressure is limited to a second maximum differential pressure.

Claims (18)

1. A reduced pressure treatment system comprising:

a reduced pressure source fluidly connected to a tissue site;

a sensing device in communication with the reduced pressure source to measure a source pressure at the reduced pressure source; and

a processing unit in communication with the sensing device and configured to determine a differential pressure between the source pressure and a desired tissue site pressure, the processing unit further being in communication with the reduced pressure source and regulating the source pressure applied by the reduced pressure source such that the differential pressure does not exceed (a) a first maximum differential pressure if a blockage is present between the reduced pressure source and the tissue site and (b) a second maximum differential pressure if no blockage is present between the reduced pressure source and the tissue site wherein the second maximum differential pressure is greater than the first maximum differential pressure.

2. The system according to claim 1 further comprising:

a canister fluidly connected between the tissue site and the reduced pressure source; and

wherein the sensing device measures the source pressure at the canister to approximate a pressure output of the reduced pressure source.

3. The system according to claim 1 , wherein the first maximum differential pressure is about 50 mm Hg.

4. The system according to claim 1 , wherein the second maximum differential pressure is about 100 mm Hg.

5. The system according to claim 1 , wherein:

when the blockage is present, the processing unit is further configured to increase the source pressure, within a limit of the first maximum differential pressure, to clear the blockage.

6. The system according to claim 5 , further comprising:

an alarm device in communication with the processing unit to alert a user when the blockage is unable to be cleared after reaching the first maximum differential pressure.

7. The system according to claim 1 , wherein the processing unit is further configured to change the source pressure, within a limit of one of the first and second maximum differential pressures, to cause a pressure at the tissue site to reach the desired tissue site pressure.

8. The system according to claim 1 , wherein the processing unit is further configured to check for the presence of the blockage by changing the source pressure and monitoring for a change in a pressure at the tissue site.

9. The system according to claim 8 , wherein the processing unit determines that the blockage is present when no directionally corresponding change in the pressure at the tissue site occurs by changing the source pressure.

10. The system according to claim 1 further comprising:

a second sensing device, the second sensing device monitoring the tissue site to determine if a pressure at the tissue site reaches the desired tissue site pressure.

Assignments (10)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066430/0333 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064790/0085 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Feb 6, 2017
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: KCI LICENSING, INC., AS GRANTOR; TECHNIMOTION, LLC, A DELAWARE LIMITED LIABILITY COMPANY, AS GRANTOR; SYSTAGENIX WOUND MANAGEMENT (US), INC., A DELAWARE CORPORATION, AS GRANTOR
Reel/Frame 041395/0044 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
RELEASE OF SECURITY INTEREST Recorded Sep 21, 2016
From: WILMINGTON TRUST
To: KCI LICENSING, INC.; LIFECELL CORPORATION; KINETIC CONCEPTS, INC.; TECHNIMOTION, LLC
Reel/Frame 040098/0200 →
SECURITY AGREEMENT Recorded Nov 8, 2011
From: KCI LICENSING, INC.; LIFECELL CORPORATION; TECHNIMOTION, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 027194/0447 →
SECURITY AGREEMENT Recorded Nov 7, 2011
From: KCI LICENSING, INC.; LIFECELL CORPORATION; TECHNIMOTION, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 027185/0174 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2007
From: KELCH, RANDALL P.; ZHENG, XIAOLU; EDGAR JR., REUBEN W.; JAEB, JONATHAN PAUL; LAWHORN, THOMAS PAUL; INGRAM, SHANNON C.
To: KCI LICENSING, INC.
Reel/Frame 020141/0287 →